Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation
NCT ID: NCT04356378
Last Updated: 2024-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
149 participants
OBSERVATIONAL
2020-06-02
2022-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Fatigue is a major component of COVID-19. Global muscular weakness is related to immobility, inflammation, corticosteroids treatment, hypoxemia due to pulmonary and/or cardiac infectious attacks and undernutrition suggests major physical functional repercussions. Thus, patients affected by COVID-19 with acute hospital management require sometimes complex rehabilitation management.
Retrospective studies on physical functional capacities in patients infected with SARS CoV1 showed long term physical activity limitations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rehabilitation of Fatigue in Patients with Post-COVID-19 Syndrome
NCT06814379
Rehabilitation After Admission in Intensive Care Unit for COVID-19
NCT04523051
Rehabilitation Program for the Sequelae of COVID 19 Infection
NCT04852718
Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors
NCT04767477
Long-Covid in Patients Post Rehabilitation Treatment and Reintegration Into Everyday Life
NCT05755542
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
"infection with coronavirus SARS-CoV2" group
"SARS-CoV2 infected patients" group: in-patient in the acute phase then requiring rehabilitation.
Data record
Data record
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data record
Data record
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* in-patient hospitalization in the acute phase because SARS-CoV2 infection
* patient requiring rehabilitation after SARS-CoV2 infection acute phase
* patient adult, aged more than 18 years old
* patient accepting to participate in the study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CHU de Reims
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Damien JOLLY
Reims, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PO20055
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.